These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 34852820

  • 1. Circulating noncoding RNAs as early predictive biomarkers in preeclampsia: a diagnostic meta-analysis.
    Su S, Yang F, Zhong L, Pang L.
    Reprod Biol Endocrinol; 2021 Dec 01; 19(1):177. PubMed ID: 34852820
    [Abstract] [Full Text] [Related]

  • 2. Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis.
    Zhao L, Li J, Xue Z, Wang J.
    Clin Transl Oncol; 2024 Jun 01; 26(6):1497-1507. PubMed ID: 38227115
    [Abstract] [Full Text] [Related]

  • 3. Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles.
    Wang J, Gao Y, Wang X, Gao Y, Li L, Zhang J, Zhang L, Che F.
    Int J Biol Markers; 2020 Jun 01; 35(2):40-48. PubMed ID: 32460591
    [Abstract] [Full Text] [Related]

  • 4. Non-Coding RNAs as Circulating Biomarkers for the Diagnosis of Intracranial Aneurysm: A Systematic Review and Meta-Analysis.
    Wu Y, Zheng J, Sun Y, Wang X, Zhao H, Qiu F, Zhang S, Jiang X, Yu X.
    J Stroke Cerebrovasc Dis; 2021 Jun 01; 30(6):105762. PubMed ID: 33813080
    [Abstract] [Full Text] [Related]

  • 5. Circulating microRNAs as biomarkers for diagnosis and prediction of preeclampsia: A systematic review and meta-analysis.
    Yin Y, Liu M, Yu H, Zhang J, Zhou R.
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct 01; 253():121-132. PubMed ID: 32871438
    [Abstract] [Full Text] [Related]

  • 6. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
    Lee YR, Kim G, Tak WY, Jang SY, Kweon YO, Park JG, Lee HW, Han YS, Chun JM, Park SY, Hur K.
    Int J Cancer; 2019 Mar 15; 144(6):1444-1452. PubMed ID: 30338850
    [Abstract] [Full Text] [Related]

  • 7. Circulating Non-coding RNAs and Exosomes: Liquid Biopsies for Monitoring Preeclampsia.
    Li N, Gu Y, Tang J, Li Y, Chen D, Xu Z.
    Methods Mol Biol; 2023 Mar 15; 2695():263-277. PubMed ID: 37450125
    [Abstract] [Full Text] [Related]

  • 8. The Value of Circulating microRNAs for Diagnosis and Prediction of Preeclampsia: a Meta-analysis and Systematic Review.
    Qin S, Sun N, Xu L, Xu Y, Tang Q, Tan L, Chen A, Zhang L, Liu S.
    Reprod Sci; 2022 Nov 15; 29(11):3078-3090. PubMed ID: 34817849
    [Abstract] [Full Text] [Related]

  • 9. A diagnostic test accuracy meta-analysis of maternal serum ischemia-modified albumin for detection of preeclampsia.
    Seshadri Reddy V, Munikumar M, Duggina P, Varma N.
    J Matern Fetal Neonatal Med; 2019 Jul 15; 32(13):2173-2181. PubMed ID: 29325458
    [Abstract] [Full Text] [Related]

  • 10. Circulating long noncoding RNAs as potential biomarkers for stomach cancer: a systematic review and meta-analysis.
    Cao F, Hu Y, Chen Z, Han W, Lu W, Xu J, Ding H, Shen X.
    World J Surg Oncol; 2021 Mar 26; 19(1):89. PubMed ID: 33771184
    [Abstract] [Full Text] [Related]

  • 11. Noninvasive preeclampsia prediction using plasma cell-free RNA signatures.
    Zhou S, Li J, Yang W, Xue P, Yin Y, Wang Y, Tian P, Peng H, Jiang H, Xu W, Huang S, Zhang R, Wei F, Sun HX, Zhang J, Zhao L.
    Am J Obstet Gynecol; 2023 Nov 26; 229(5):553.e1-553.e16. PubMed ID: 37211139
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
    Li B, Pu K, Ge L, Wu X.
    Gene; 2019 Sep 25; 714():143993. PubMed ID: 31330238
    [Abstract] [Full Text] [Related]

  • 13. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L, Hu C, Huang Z, Li Z, Zhang Q, He Y.
    PLoS One; 2021 Sep 25; 16(4):e0250717. PubMed ID: 33901236
    [Abstract] [Full Text] [Related]

  • 14. Serum cystatin-c as predictive factor of preeclampsia: A meta-analysis of 27 observational studies.
    Bellos I, Fitrou G, Daskalakis G, Papantoniou N, Pergialiotis V.
    Pregnancy Hypertens; 2019 Apr 25; 16():97-104. PubMed ID: 31056166
    [Abstract] [Full Text] [Related]

  • 15. Long Non-Coding RNAs Serve as Diagnostic Biomarkers of Preeclampsia and Modulate Migration and Invasiveness of Trophoblast Cells.
    Luo X, Li X.
    Med Sci Monit; 2018 Jan 05; 24():84-91. PubMed ID: 29302021
    [Abstract] [Full Text] [Related]

  • 16. Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia: A Systematic Review and Meta-analysis.
    Lim S, Li W, Kemper J, Nguyen A, Mol BW, Reddy M.
    Obstet Gynecol; 2021 Jan 01; 137(1):72-81. PubMed ID: 33278298
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic potential of circulating LncRNAs in human cardiovascular disease: a meta-analysis.
    Luo F, Wang T, Zeng L, Zhu S, Cao W, Wu W, Wu H, Zou T.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30361292
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies.
    Liu Y, Zhao Y, Yu A, Zhao B, Gao Y, Niu H.
    Arch Gynecol Obstet; 2015 Sep 21; 292(3):507-18. PubMed ID: 25716670
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.